Добірка наукової літератури з теми "Chaîne de distribution pharmaceutique"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Chaîne de distribution pharmaceutique".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Chaîne de distribution pharmaceutique"
Santini, C. "La « chaîne pharmaceutique », atout essentiel de sécurité sanitaire en France. Synthèse de la séance." Annales Pharmaceutiques Françaises 66, no. 5-6 (November 2008): e9-e12. http://dx.doi.org/10.1016/j.pharma.2008.10.002.
Повний текст джерелаSimier, Paul. "Le contrôle de la chaîne de distribution." Téoros: Revue de recherche en tourisme 9, no. 3 (1990): 3. http://dx.doi.org/10.7202/1079882ar.
Повний текст джерелаAtchadé, Félix. "L’Afrique face à l’industrie pharmaceutique." La Pensée N° 417, no. 1 (March 18, 2024): 119–27. http://dx.doi.org/10.3917/lp.417.0119.
Повний текст джерелаCorbin, Elsa. "Paiement à la prestation et PSL : vers une gestion dynamique de la chaîne logistique pharmaceutique aux Etats-Unis." Logistique & Management 16, no. 2 (January 2008): 69–80. http://dx.doi.org/10.1080/12507970.2008.11516902.
Повний текст джерелаMonnoyer, Marie-Christine. "L’EDI dans la grande distribution." Décisions Marketing N° 0, no. 1 (January 1, 1993): 73–84. http://dx.doi.org/10.3917/dm.0a.0073.
Повний текст джерелаdes Garets, Véronique, Pierre-Louis Dubois, and Alain Paccou. "Théories de la distribution et pratique de l’EDI chez Auchan." Décisions Marketing N° 0, no. 1 (January 1, 1993): 87–92. http://dx.doi.org/10.3917/dm.0a.0087.
Повний текст джерелаCouacy-Hymann, Emmanuel, Angeli Kodjo, M. Ouattara, K. Kanga, S. Diawara, and Joseph Domenech. "Le contrôle de qualité des vaccins et de la chaîne du froid lors des campagnes nationales de vaccination." Revue d’élevage et de médecine vétérinaire des pays tropicaux 45, no. 2 (February 1, 1992): 129–33. http://dx.doi.org/10.19182/remvt.8936.
Повний текст джерелаMoinier, Xavier. "L’enseigne de pharmaciens : une spécificité au cœur de la distribution." Décisions Marketing N° 53, no. 1 (January 1, 2009): 7–17. http://dx.doi.org/10.3917/dm.053.0007.
Повний текст джерелаSimonot, F. "Sur l'approximation de la distribution stationnaire d'une chaîne de Markov stochastiquement monotone." Stochastic Processes and their Applications 56, no. 1 (March 1995): 133–49. http://dx.doi.org/10.1016/0304-4149(94)00062-x.
Повний текст джерелаSanogo, Moussa, Aboubacar Alassane Oumar, Saïbou Maiga, Lisette Corine Coovi, Ibrahima Koita, Aissata Traore, and Moussa Harama. "Respect des bonnes pratiques de distribution dans un établissement de distribution pharmaceutique du Mali : bilan et perspectives." Le Pharmacien Hospitalier 43, no. 174 (September 2008): 135–40. http://dx.doi.org/10.1016/s0768-9179(08)74196-8.
Повний текст джерелаДисертації з теми "Chaîne de distribution pharmaceutique"
Chapuis, Charles. "Qualification et validation d'une chaine de production et de distribution d'eau distillée dans l'industrie pharmaceutique." Bordeaux 2, 1996. http://www.theses.fr/1996BOR2P011.
Повний текст джерелаAit, Mamoun Khadija. "Vehicle rοuting prοblem under uncertainty : case οf pharmaceutical supply chain". Electronic Thesis or Diss., Normandie, 2024. http://www.theses.fr/2024NORMIR08.
Повний текст джерелаThe enhancement of logistics distribution performance and the optimization of transportation have emerged as critical concerns in recent years. The pharmaceutical distribution sector faces significant challenges in route planning and transport network optimization, with uncertainties often leading to delays and losses. The multifaceted challenges encompass the imperative to elevate product quality, reduce costs, minimize total travel distance, and streamline transportation time for effective planning. Within this context, the Vehicle Routing Problem (VRP) stands out as one of the extensively analysed problems in the realms of transportation, distribution, and logistics. Achieving a delicate equilibrium between cost considerations and delivering high-quality pharmaceutical products is a primary objective in pharmaceutical distribution. This research delves into both the Static Vehicle Routing Problem (SVRP) and the Dynamic Vehicle Routing Problem (DVRP). Real-world logistical planning frequently encounters uncertainties at the outset, including uncertain customer demand, delivery quantities, time constraints, and more. This thesis introduces the "temperature condition" as a fundamental constraint in pharmaceutical distribution, representing a source of uncertainty that directly impacts drug quality, thereby influencing logistics distribution and overall supply chain performance. Furthermore, the thesis incorporates uncertainty quantification for modelling uncertain travel times in both recurrent and non-recurrent congestion scenarios. The methodology employed for this purpose is the collocation method, initially validated through Monte Carlo Simulation (MCS). By addressing these multifaceted challenges and uncertainties, this research seeks to contribute to the development of robust strategies in pharmaceutical distribution, ensuring the optimization of routes, reduction of costs, and maintenance of high-quality product standards. The findings of this study offer valuable insights for logistics managers and planners aiming to navigate the complexities of pharmaceutical distribution, fostering efficiency and resilience in the face of uncertainties
Bouazza, Diden. "La distribution des médicaments en Algérie : étude comparative." Clermont-Ferrand 1, 1988. http://www.theses.fr/1988CLF10060.
Повний текст джерелаThe study of medecine delivery in Algeria gives us a reflection about pharmaceutics policy since national independance. Beyong transformations, the distribution plan, based on a liberal concept, reveals a lag in the pre-arranged options. Manufacturing monopolization of medecines shows the problem of delivery structures ; importing stiel remains the man feature of health planing in the country. Aucht socialization makes the consumer interest rank below. The system measure allows to set up professionals passivity or that of chemists, not only within the delivery flour, but also within the organism in which it defends its profession. The professional's formation and information shows the advantage of setting the problem of medecine delivery to the consumer. The chemist's statue is rather badly defined, and althought the latter is contrained to strict obligations in professional practising, his intervention remains limited in the consume's education - his advices and information are lacking. This call a rational delivery of the medicine in question. However, as for a specific activity, delivering medicines must deal with severe rules in order to protect public health in addition to these restaints, the chemist has to deal with the inflingements done within the profession
Harreguy, Annabelle. "L'externalisation de la distribution pharmaceutique en France : les prestataires logistiques." Bordeaux 2, 2000. http://www.theses.fr/2000BOR2P018.
Повний текст джерелаDesgrippes, Emmanuel. "Coordination entre la production et la distribution dans une chaîne logistique." Grenoble INPG, 2005. http://www.theses.fr/2005INPG0072.
Повний текст джерелаThis thesis deals with the coordination between different activities in a supply chain, actually between the production and the distribution of finished goods. It is inspired of an industrial case of production and distribution of pick-ups in Thailand. First the problem is modeled as a mixed integer linear program optimizing bath production and distribution. Then the coordination is approached focusing on the production part and then on the transportation part. The distribution problem on a tree (due to the specifie shape of the network) is solved with sorne assumptions, the general problem being NP-complete. The production problem, considered separately, is also solved by a polynomial algorithm. We also show a link between production and distribution on a single line network, and batch scheduling. We propose an efficient dynamic programming procedure to solve this special case. Finally, heuristics based on list algorithms are designed to deal with the coordination problem
Estime, Nicolas. "Contrôle des propriétés des cristaux d'un principe actif pharmaceutique dans la chaîne précipitation - filtration - séchage : vers un procédé continu." Thesis, Toulouse, INPT, 2010. http://www.theses.fr/2010INPT0069.
Повний текст джерелаThis study deals with the development of a methodology allowing to transform a batch precipitation process in a continuous one. The active substance considered is acetyl-L-leucine. The work is focused on the precipitation step but also considers the interactions with the downstream processes of filtration, washing and drying. In a first part, characterization methods of pure and impure solutions of active substance were developed as well as methods for determining the crystals properties (purity, size, size distribution, shape, ...). Then the solubility of the product was investigated and the influence of parameters such as temperature, pH, impurity concentration, was studied. The crystallization mode of the racemic mixtures was also determined . Finally, batch crystallization was carried out at the laboratory scale in order to determine nucleation kinetics and to understand the main operating parameters influencing the quality of the crystals. For the applied range of concentrations, the induction time was found very small and indicates that the control of the nucleation step is difficult and depends on the mixing of the reactants. The whole continuous process was finally designed and tested, from the initial reactive to the final dry ZPI powder, in industrial site to validate the feasibility of the continuous process
Testanière, Denis. "Stratégies de distribution et organisations d'achat : évolution en industrie pharmaceutique et parapharmaceutique." Paris 1, 1993. http://www.theses.fr/1993PA010046.
Повний текст джерелаThe traditional distribution network of pharmaceutics includes very different products: the prescribed medecines, the "over the counter" drugs and the other products sold in a drugstore (cosmetics and accessories). The usual networks of distribution, mainly the pharmacy, are questioned under the pressure of several factors related to the concept of health cost, related to the knowledge of customers needs or related to the development of communication. The competition with other commerces, the selective distribution (perfumeries, "grands magasins"), the stores ("hypermarches") or the direct marketing ("vente par correspondance"), is difficult and involves deep changes of the present pharmacy organization. The chemist's shops are reacting by gathering, in the form of "groupements" which aspire to turn into a real distribution net work or a franchised network. On the one hand the present set of laws regarding to the pharmacies and on the other hand the turn of mind of some independant druggists restrict this trend. Nevertheless, the distribution network is beeing transformed into health-specialized stores, organized by chains of shops which will provide a large choice of prices and a self-service department concerning a lot of products, including the "automedication" drugs (which will become real "over-the-counter" drugs). These stores will exist beside smaller shops, with a high degree of specialization, veterinary drugs-specialized or orthopedics-specialized for example. In any case, the most important factors of the future distribution network success will be the advices and the quality of service
Corbin, Elsa. "Enjeux et limites de l'introduction du supply chain management dans la chaîne logistique pharmaceutique : une perspective des grossistes répartiteurs portoricains." Antilles-Guyane, 2006. http://www.theses.fr/2006AGUY0580.
Повний текст джерелаIn United States, the pharmaceutical laboratories have decided to tackle the numerous sources of wastes existing in the pharmaceutical supply chain. Although we are still far from a generalization of these practices, as well we are far from a generalization of supply chain management practices in the pharmaceutical supply chain, lean manufacturing and the introduction of the Inventory Management Agreement (IMA) --announcing the beginning of a new era in the drug supply chain--are the new solutions introduced in order to reach a better pharmaceutical supply chain management The Inventory Management Agreement, signed between the pharmaceutical laboratories and the wholesalers -who, during years, managed the drug marketing channel-, should help today to leave behind speculative strategies in favour of practices permitting to decrease the level of stocks all along the drug supply chain. The transformations that the laboratories want to impulse reconsider the presence of the wholesalers as essential actors within the pharmaceutical supply chain. These ones are forced to introduce supply chain management practices as they do not want to be seen as an obstacle for an efficient management of the supply chain preventing them to be, in the future, maintained as a full actor within the drug supply chain
Hichri, Gaël. "La distribution pharmaceutique : Essai sur l'organisation d'un secteur économique réglementé en droit privé." Montpellier 1, 2007. http://www.theses.fr/2007MON10049.
Повний текст джерелаThe distribution of pharmaceutical products is a highly regulated economic sector. Seen from a private law standpoint, it is considered a matter of economic public order, and its regulation covers, by definition, contractual relationships between distributors in so far as such contracts are the legal supports of a regulated trade. This said, the regulations do allow distributors a certain freedom to organise their commercial interests. These regulations have a single purpose: to organise pharmaceutical distribution so as to best protect the public health within a controlled financial context. In view of this, the regulating organisation of pharmaceutical distribution is based as much on a multitude of specific transactions corresponding to general obligations towards the public health, as it is upon a tightly controlled pricing framework. This organisation of distribution transactions therefore touches indirectly upon distribution contracts. So long as distributors practice their trade within the framework of these regulations, they are otherwise free to organise with their commercial interests in mind. The organization of pharmaceutical distribution can therefore be determined in an isolated manner, on the initiative of a single operator, either so as to discipline retail dealers, or so as to open up new outlets for expansion. The organization of distribution can also be managed collectively, from within pharmacy networks designed to strengthen commercial relationships between distributors. Pharmaceutical distributors have thus borrowed techniques proven effective by large-scale distribution, specialized distribution and electronic distribution. However, these modes of organization cannot be put to use as is, and must be adapted to the particularities of the pharmaceutical sector. Although the adoption of these techniques is still controversial, their study is noneless essential, since they are inevitably precursors to the future development of pharmaceutical distribution
Berrada, El Azizi Mohamed. "Modélisation multi-agents de la coopération au sein des chaînes logistiques à deux échelons : application à la distribution de produits pharmaceutiques au Maroc." Thesis, Paris 13, 2014. http://www.theses.fr/2014PA131020/document.
Повний текст джерелаAThis thesis is composed by two papers focusing on two-level supply chains with a monopoly supplier and N clients whose demands for the same products are correlated. The first paper studies the simultaneous impact of vertical and horizontal cooperation on the overall performance and the stability of the chain. It proposes an individual-centered multi-agents approach for studying the impact on performance of different kinds of customer behaviors associated with overstock risk and their interaction rules under possible distortion of the exchanged information. The second paper deals with pharmaceutical distribution and studies the influence of the cooperation between wholesale distributors and a unique supplier to reduce overstocks and wastes. More generally, this thesis has shown the relevance of a connectionist approach of complex supply chains with heterogeneous agents exchanging information
Книги з теми "Chaîne de distribution pharmaceutique"
Garnier, Catherine, and Joseph Josy Lévy. La chaîne des médicaments: Perspectives pluridisciplinaires. Québec [Que.]: Presses de l'Université du Québec, 2007.
Знайти повний текст джерелаColloque de droit pharmaceutique (1984 Université de Clermont-Ferrand I). La distribution pharmaceutique, monopole et concurrence: Colloque de droit pharmaceutique, 9-10 novembre 1984. Paris: Presses universitaires de France, 1986.
Знайти повний текст джерелаSimonet, Daniel. Alliances et stratégies de distribution dans l'industrie pharmaceutique: Une étude empirique des accords de licence et des partenariats verticaux. Grenoble: A.N.R.T, Université Pierre Mendes France (Grenoble II), 1998.
Знайти повний текст джерелаChaudhury, Ranjit Roy. Making medicines afordable: Studying WHO initiatives. Tunbridge Wells: Anshan, 2005.
Знайти повний текст джерелаLa distribution pharmaceutique, monopole et concurrence: Colloque de droit pharmaceutique, 9-10 novembre 1984. Presses universitaires de France, 1986.
Знайти повний текст джерелаHADDAD. Dangers Dans la Chaine Transformation Hb: Dangers Dans la Chaîne de Transformation et de Distribution des Denrees Alimentaires. ISTE Editions Ltd., 2022.
Знайти повний текст джерелаBiopharmaceutical supply chains: Distribution, regulatory, systems and structural changes ahead. Boca Raton, FL: CRC Press, 2012.
Знайти повний текст джерелаL'image du pays d'origine à travers la chaîne de distribution internationale: Cas des exportations des pays en voie de développement. Grenoble: A.N.R.T, Université Pierre Mendes France (Grenoble II), 2001.
Знайти повний текст джерелаLa règlementation des plateformes de diffusion numériques par le droit canadien. Teseo, 2019. http://dx.doi.org/10.55778/ts981762931.
Повний текст джерелаЧастини книг з теми "Chaîne de distribution pharmaceutique"
Rouet, François. "4. Diffusion et distribution : place et enjeux pour la filière du livre et l’offre non marchande des bibliothèques." In Les bibliothèques dans la chaîne du livre, 125. Éditions du Cercle de la Librairie, 2004. http://dx.doi.org/10.3917/elec.paye.2004.01.0125.
Повний текст джерелаRomero-Torres, Alejandro. "Chapitre 9. Comment assurer l’intégrité de la chaîne d’approvisionnement pharmaceutique : les systèmes de suivi et de traçabilité des médicaments." In Supply Chain Management de la santé, 164–81. EMS Editions, 2019. http://dx.doi.org/10.3917/ems.bent.2019.01.0164.
Повний текст джерелаDELAHAYE, Anthony, and Laurence FOURNAISON. "Utilisation des hydrates pour le stockage et la distribution du froid." In Stockage de la chaleur et du froid 1, 161–216. ISTE Group, 2023. http://dx.doi.org/10.51926/iste.9133.ch7.
Повний текст джерелаBeaulieu, Martin, and Jacques Roy. "Cas en logistique et Supply Chain Management." In Cas en logistique et Supply Chain Management, 17–29. EMS Editions, 2023. http://dx.doi.org/10.3917/ems.lavas.2023.01.0017.
Повний текст джерелаCHÈNÉ, Christine. "Les additifs comme dangers chimiques dans les aliments." In Les dangers dans la chaîne de transformation et de distribution des denrées alimentaires, 189–227. ISTE Group, 2022. http://dx.doi.org/10.51926/iste.9093.ch5.
Повний текст джерелаBRAUGE, Thomas, Stéphanie COPIN, Mélanie GAY, and Graziella MIDELET. "Les produits de la mer peu transformés et les dangers bactériens et parasitaires." In Les dangers dans la chaîne de transformation et de distribution des denrées alimentaires, 71–113. ISTE Group, 2022. http://dx.doi.org/10.51926/iste.9093.ch2.
Повний текст джерелаCAPPELIER, Jean-Michel. "La consommation de viande et les dangers biologiques." In Les dangers dans la chaîne de transformation et de distribution des denrées alimentaires, 21–69. ISTE Group, 2022. http://dx.doi.org/10.51926/iste.9093.ch1.
Повний текст джерелаDERVILLY, Gaud, Ronan CARIOU, and Bruno LE BIZEC. "Les contaminants comme dangers chimiques dans les aliments." In Les dangers dans la chaîne de transformation et de distribution des denrées alimentaires, 151–87. ISTE Group, 2022. http://dx.doi.org/10.51926/iste.9093.ch4.
Повний текст джерелаJHA, Piyush Kumar, Thierry BÉNÉZECH, Maureen DELEPLACE, and Christine FAILLE. "La contamination microbienne des surfaces des équipements dans les agro-industries." In Les dangers dans la chaîne de transformation et de distribution des denrées alimentaires, 115–49. ISTE Group, 2022. http://dx.doi.org/10.51926/iste.9093.ch3.
Повний текст джерелаCONRADSEN, Knut, Henning SKRIVER, Morton J. CANTY, and Allan A. NIELSEN. "Détection de séries de changements dans des séries d’images SAR polarimétriques." In Détection de changements et analyse des séries temporelles d’images 1, 41–81. ISTE Group, 2022. http://dx.doi.org/10.51926/iste.9056.ch2.
Повний текст джерела